5,921 results on '"Leon, Martin"'
Search Results
152. Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes From the BIONICS and NIREUS Trials
153. Resumen: Consenso internacional para la nomenclatura y clasificación de la válvula aórtica bicúspide congénita y su aortopatía, con fines clínicos, quirúrgicos, intervencionistas y de investigación
154. Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19
155. Transcatheter Versus Medical Treatment of Patients With Symptomatic Severe Tricuspid Regurgitation
156. Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis
157. Novel Multiphase Assessment for Predicting Left Ventricular Outflow Tract Obstruction Before Transcatheter Mitral Valve Replacement
158. Spray Drying Encapsulation of Pediococcus acidilactici at Different Inlet Air Temperatures and Wall Material Ratios
159. Extrapulmonary manifestations of COVID-19
160. Expanding the indications for transcatheter aortic valve implantation
161. The Smoker’s Paradox Revisited: A Patient-Level Pooled Analysis of 18 Randomized Controlled Trials
162. 3-Year Outcomes of the DKCRUSH-V Trial Comparing DK Crush With Provisional Stenting for Left Main Bifurcation Lesions
163. Incidence and Outcomes of Surgical Bailout During TAVR: Insights From the STS/ACC TVT Registry
164. Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement
165. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation
166. Staging Cardiac Damage in Patients With Symptomatic Aortic Valve Stenosis
167. 3-Year Outcomes After Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprostheses: The PARTNER 2 Registry
168. Time-of-Day and Clinical Outcomes After Surgical or Transcatheter Aortic Valve Replacement: Insights From the PARTNER Trials
169. Impact of Frailty and Prefrailty on Outcomes of Transcatheter or Surgical Aortic Valve Replacement
170. Standardized Invasive Hemodynamics for Management of Patients With Elevated Echocardiographic Gradients Post-Transcatheter Aortic Valve Replacement at Midterm Follow-Up
171. The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study
172. Impact of Short-Term Complications on Mortality and Quality of Life After Transcatheter Aortic Valve Replacement
173. Case Volume and Outcomes After TAVR With Balloon-Expandable Prostheses: Insights From TVT Registry
174. Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry
175. Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis
176. Glatiramer acetate persists at the injection site and draining lymph nodes via electrostatically-induced aggregation
177. The “Eyeball Test” for Risk Assessment in Aortic Stenosis: Characterizing Subjective Frailty Using Objective Measures
178. Effect of Functional Mitral Regurgitation on Outcome in Patients Receiving Cardiac Resynchronization Therapy for Heart Failure
179. Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial
180. Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial
181. Intravascular Ultrasound–Derived Calcium Score to Predict Stent Expansion in Severely Calcified Lesions
182. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
183. Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge‐to‐edge repair ‐ Results from TriValve Registry
184. Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation
185. Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years
186. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
187. TCT-411 In-hospital Characteristics and Outcomes Among Patients With Acute Heart Failure Undergoing Transcatheter Aortic Valve Replacement
188. TCT-331 Cardiac Damage Staging Predicts Outcomes in Symptomatic and Asymptomatic Aortic Valve Stenosis After Aortic Valve Replacement: Meta-Analysis of Reconstructed Time-to-Event Data
189. Characterization of Left Atrial Appendage Closure Device Protrusion and Implications for Transcatheter Mitral Valve Replacement
190. TCT-641 Intravascular Imaging-Guided Versus Angiography-Guided Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials
191. TCT-505 CKD Risk Stratification Within a Cohort of Patients Undergoing Ultralow-Contrast IVUS-Guided PCI
192. Diastolic Dysfunction and Health Status Outcomes After Transcatheter Aortic Valve Replacement
193. Bleeding Outcomes in Patients Undergoing Combined Percutaneous Coronary Interventions+Transcatheter Aortic Valve Replacement: Time for an Adjustment to the CathPCI Bleeding Model?
194. Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain
195. Incidence and Clinical Significance of Worsening Tricuspid Regurgitation Following Surgical or Transcatheter Aortic Valve Replacement: Analysis From the PARTNER IIA Trial
196. Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial
197. Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial
198. The 21st Century Cures Act and Early Feasibility Studies for Cardiovascular Devices: What Have We Learned, Where Do We Need to Go?
199. Outcomes of Patients with Significant Obesity Undergoing TAVR or SAVR in the Randomized PARTNER 2A Trial
200. Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.